BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 6, 2008
View Archived Issues
Deciphera's B-Raf Inhibitor Program Lands Deal with Lilly
Privately held Deciphera Pharmaceuticals LLC signed its first big pharma deal, licensing rights to four preclinical B-Raf kinase inhibitors to Eli Lilly and Co. for the development of oncology drugs. (BioWorld Today)
Read More
Another Case of PML: This Time Raptiva is Implicated
Read More
Repros Looks Inside to Close $15.5M Registered Direct Deal
Read More
NCI Studying Biomarker Use in Lung Cancer Treatment
Read More
Judge Says Amgen Entitled to Permanent Injunction in EPO Case
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Clinic Roundup
Read More